Figure 1 Mean (±sd) Silodosin Steady State Plasma Concentration-time Profile In Healthy Target-aged Subjects Following Silodosin 8 mg Once Daily With Food (Silodosin Fig1)
Silodosin Capsule
Product Images NDC 59651-096
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Silodosin (NDC 59651-096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 Mean Change From Baseline In Ipss Total Score By Treatment Group And Visit In Study 1 (Silodosin Fig2)
The text describes the change from baseline in IPSS Total Score for a medication called Siladosin 8 mg compared to the placebo, and displays the statistical significance of the result with a p-value of less than 0.0001. The text also includes some alphanumeric codes which are not clearly interpretable.*
Figure 3 Mean Change From Baseline In Ipss Total Score By Treatment Group And Visit In Study 2 (Silodosin Fig3)
The text describes the change from baseline in IPSS total score, with reference to a statistical significance of p<0.0001. However, without additional context or information, it is not possible to determine what the IPSS score represents, what the AAAPhcebo and iocosin 8 mg refer to, or what the B a5 7 and Day 84/LOCF signify.*
Figure 4 Mean Change From Baseline In Qmax (ml/sec) By Treatment Group And Visit In Study 1 (Silodosin Fig4)
Figure 5 Mean Change From Baseline In Qmax (ml/sec) By Treatment Group And Visit In Study 2 (Silodosin Fig5)
Package Label-principal Display Panel (4 mg (30 Capsules Bottle))
Silodosin Capsules 4mg, distributed by Aurobindo Pharma USA, Inc. in a bottle with 30 capsules. The usual dosage is one capsule taken orally once daily with a meal as per the packaging insert for full prescribing information. Made in India. Store the medication between 20°C to 25°C and protect from light and moisture. Keep out of reach of children. Not available for the purpose of the coding area.*
Package Label-principal Display Panel (8 mg (30 Capsules Bottle))
Each Silodosin capsule contains & mg which is a medicine distributed by Aurabindo Pharma USA. It is recommended to take the medicine once a day with a meal. For detailed prescribing information, please see the package insert. The medicine should be stored and dispensed in controlled room temperature and protected from light and moisture. The medicine is available in the form of 20/255/76/152 capsules. It is a prescription drug made in India. Keep out of reach of children.*
Silodosin Chemical Structure (Silodosin Str)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
